The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article

Pagès et al. 353 (25): 2654, Figure 2     December 22, 2005


-  Return to Article  -  Add to Personal Archive  -  PowerPoint Help



Figure 2. Expression of Inflammatory Genes, Immunosuppressive Genes, and Genes Related to the Adaptive Immune Response in a Series of 75 Colorectal Cancers, According to the Presence or Absence of Any Sign of Early Metastatic Invasion and Relapse.

Early metastatic invasion was defined by the presence of vascular emboli, lymphatic invasion, and perineural invasion (collectively referred to as VELIPI), alone or in combination. Relative levels of expression of mRNA were adjusted for the level of 18S mRNA for each sample. The levels are represented as mean percentage (+SE) increases as compared with levels in the group of patients with VELIPI-positive tumors who had a relapse, and P values are for the comparison with the reference group. VEGF denotes vascular endothelial growth factor, CEACAM-1 carcinoembryonic-antigen–related cell-adhesion molecule, MMP-7 matrix metalloproteinase 7, TGF-{beta} transforming growth factor {beta}, T-BET T-box transcription factor 21, and IRF-1 interferon regulatory factor 1.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.